Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Cash from Financing Activities (2022 - 2025)

Neuraxis (NRXS) has disclosed Cash from Financing Activities for 4 consecutive years, with $2.6 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 49.4% to $2.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.8 million through Dec 2025, down 19.62% year-over-year, with the annual reading at $7.8 million for FY2025, 19.62% down from the prior year.
  • Cash from Financing Activities hit $2.6 million in Q4 2025 for Neuraxis, up from -$183808.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $5.5 million in Q2 2025 to a low of -$183808.0 in Q3 2025.
  • Historically, Cash from Financing Activities has averaged $1.8 million across 4 years, with a median of $1.1 million in 2022.
  • Biggest five-year swings in Cash from Financing Activities: surged 419.48% in 2024 and later crashed 105.17% in 2025.
  • Year by year, Cash from Financing Activities stood at $510009.0 in 2022, then soared by 284.88% to $2.0 million in 2023, then skyrocketed by 164.61% to $5.2 million in 2024, then tumbled by 49.4% to $2.6 million in 2025.
  • Business Quant data shows Cash from Financing Activities for NRXS at $2.6 million in Q4 2025, -$183808.0 in Q3 2025, and $5.5 million in Q2 2025.